VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2024. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $770,000 | +41.3% | 33,141 | -3.1% | 0.00% | +33.3% |
| Q1 2018 | $545,000 | -31.0% | 34,197 | -10.0% | 0.00% | -40.0% |
| Q4 2017 | $790,000 | +9.6% | 38,014 | -24.5% | 0.01% | 0.0% |
| Q3 2017 | $721,000 | -28.5% | 50,369 | -13.5% | 0.01% | -37.5% |
| Q2 2017 | $1,008,000 | +45.2% | 58,230 | -7.6% | 0.01% | +33.3% |
| Q1 2017 | $694,000 | +25.3% | 62,987 | +65.0% | 0.01% | 0.0% |
| Q4 2016 | $554,000 | +90.4% | 38,181 | +163.8% | 0.01% | +50.0% |
| Q2 2016 | $291,000 | +250.6% | 14,471 | +357.5% | 0.00% | +300.0% |
| Q1 2016 | $83,000 | -34.1% | 3,163 | +155.7% | 0.00% | -66.7% |
| Q4 2015 | $126,000 | +13.5% | 1,237 | +98.2% | 0.00% | 0.0% |
| Q3 2015 | $111,000 | +6.7% | 624 | +33.0% | 0.00% | 0.0% |
| Q2 2015 | $104,000 | +11.8% | 469 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $93,000 | +29.2% | 469 | -7.3% | 0.00% | +50.0% |
| Q4 2014 | $72,000 | +323.5% | 506 | +301.6% | 0.00% | +100.0% |
| Q3 2014 | $17,000 | -45.2% | 126 | -48.6% | 0.00% | 0.0% |
| Q2 2014 | $31,000 | +34.8% | 245 | +39.2% | 0.00% | 0.0% |
| Q1 2014 | $23,000 | +187.5% | 176 | +166.7% | 0.00% | – |
| Q4 2013 | $8,000 | -50.0% | 66 | -56.0% | 0.00% | -100.0% |
| Q3 2013 | $16,000 | +166.7% | 150 | +130.8% | 0.00% | – |
| Q2 2013 | $6,000 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |